Page 5 - 《中国药房》2022年12期
P. 5

CHINA PHARMACY

                               Volume 33,Number 12,June 30,2022

                                                 Semimonthly
                                             Table of Contents



        Construction of total quality management system of clinical comprehensive evaluation of drugs in China ………
          ………………… ZHAO Rui,HU Ruofei,SHI Xiuyuan,SHEN Aizong,CHEN Yongwu,LI Fan,ZHAO Kun(1409)

        Exploration of influential factors for job satisfaction of pharmacists in secondary and tertiary hospitals of China
          ………………………… LIN Chenglong,LYU Juan,LIU Yueyue,WANG Zhitao,WANG Qinxue,XI Xiaoyu(1415)
        Effects of Zhilong huoxue tongyu capsules on intracerebral hemorrhage,LncRNA and target genes in mice ……
          ……………………………………………… TAN Ruizhi,ZHONG Xia,WANG Li,YANG Sijin,XU Houping(1421)
        Establishment of fingerprints,anti-inflammatory activities and spectrum-effect relationship study of pith-nodecayed
          and pith-decayed Scutellaria baicalensis …………………………………………………………………………
          ………………… JIA Chuanqing,GUO Lanping,WANG Xiao,YU Zongyuan,CHEN Long,DONG Hongjing(1430)

        Effects of arctiin relieving inflammatory injury of human nasopharyngeal epithelial cells induced by lipopolysac-
          charide …………………… NIE Falong,ZHAO Xianfang,ZHU Zimo,JIANG Zixian,DAI Rong,LI Xiufang(1436)
        Study on drying methods and harvesting time of Gynura divaricata leaf based on main active constituents ……
          ………… WU Yingru,LI Yuanyuan,LI Ning,GUO Dingding,GUO Fugui,LAN Zijun,ZHAO Linru,NI Yan(1442)
        Inhibitory effects of gallic acid on human esophageal cancer TE-1 cells in vitro and its mechanism ……………
          ……………………………………………………………… WU Hao,Nuran·Baydolla,LIU Linyu,REN Yanli(1448)
        Determination of four ephedrine components in Banxialu granules by QuEChERS combined with UHPLC-MS/MS
          …………………………………………… YAN Liang,DING Yinping,CHEN Weikang,LIU Dehong,LI Jing(1455)
        Study on the effects and mechanism of saltwater stir-baked Eucommia ulmoides on kidney-yang deficiency in rats

          ……………………………… CHENG Fen,YANG Changhua,SONG Yanli,DU Bei,LIU Feng,HU Benxiang(1460)
        Cost-utility analysis of pembrolizumab combined with chemotherapy in the first-line treatment of advanced or
          metastatic esophageal carcinoma ………… QI Ran,DU Guiping,LIU Xuting,GAO Shengnan,LIU Guoqiang(1466)
        Analysis of influential factors of direct economic burden of AECOPD patients in hospital and related suggestions
          ………………………………………………… YE Jiankeng,MENG Xiao,WU Yaozhou,LIU Zixuan,WEI Li(1474)
        Pharmacoeconomic evaluation of ensatinib in the first-line treatment of anaplastic lymphoma kinase-positive
          advanced non-small cell lung cancer ………………… SUN Lei,ZHOU Dachuang,CHEN Pingyu,MA Aixia(1479)

        Mining and analysis of glucagon-like peptide-1 receptor agonists related adverse drug reaction signals based on
          openFDA database …………………………………………………………… DONG Shichao,WANG Jingyu(1485)
        Meta-analysis of clinical efficacy and safety of blinatumomab for acute lymphoblastic leukemia …………………
          ………………………………………………………………………………… YANG Yongjie,ZHANG Qiwen,
          LU Jingli,GUAN Kelei,LIU Kefeng,YANG Nan,DU Shuzhang,KANG Jian,ZHANG Xiaojian(1492)
        A case of tracheomediastinal fistula associated with bevacizumab after radiation and literature review …………
          ………………………………………………………………………… DU Zhongying,LIU Fang,CUI Huijuan(1500)
        Optimization and practice in pre-review rules of traditional Chinese medicine prescription in medical institutions

          ……………………… ZHANG Ting,GU Jie,DING Lanping,MA Zhuyue,ZHANG Duxiao,YUAN Hongyu(1506)
        Research progress of pharmacokinetic factors of metformin …………………………………………………………
          SHEN Yike,Niyangzhuoma,HU Lin,QIN Ningning,LI Wenbin,ZHAO Anpeng,WANG Rong,SUN Yuemei(1513)
        Progress in individualized use of linezolid in adult critically ill patients … ZHANG Ming,LI Guofei,SUN Hao(1520)
   1   2   3   4   5   6   7   8   9   10